Katagiri, K.; Arakawa, S.; Hatano, Y.; Fujiwara, S. (2006). „Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata”. The Journal of Dermatology. 33 (2): 75. PMID16556272. doi:10.1111/j.1346-8138.2006.00017.x.
Kawai, SH; Hambalek, RJ; Just, G (1994). „A facile synthesis of an oxidation product of terfenadine”. J. Org. Chem. 59 (9): 2620—22. doi:10.1021/jo00088a056.
nih.gov
ncbi.nlm.nih.gov
Lappin G, Shishikura Y, Jochemsen R, Weaver RJ, Gesson C, Houston B, Oosterhuis B, Bjerrum OJ, Rowland M, Garner C (2010). „Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability”. Eur J Pharm Sci. 40 (2): 125—31. PMID20307657. doi:10.1016/j.ejps.2010.03.009.
Katagiri, K.; Arakawa, S.; Hatano, Y.; Fujiwara, S. (2006). „Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata”. The Journal of Dermatology. 33 (2): 75. PMID16556272. doi:10.1111/j.1346-8138.2006.00017.x.
Vena GA, Cassano N, Filieri M, Filotico R, D'Argento V, Coviello C (2002). „Fexofenadine in chronic idiopathic urticaria: a clinical and immunohistochemical evaluation”. Int J Immunopathol Pharmacol. 15 (3): 217—24. PMID12575922.